Literature DB >> 2362906

Altered pharmacokinetics and dynamics of apomorphine in the malnourished rat: modeling of the composed relationship between concentration and heart-rate response.

E Bredberg1, L K Paalzow.   

Abstract

The impact of malnutrition on the pharmacokinetics and pharmacodynamics (change in heart rate) of apomorphine was studied in the rat. One group of rats received a low-protein diet (0.5%) ad libitum to produce prekwashiorkor. The control group received commercial food pellets. In the first experiment, the two groups received a 2 mg/kg iv bolus dose of apomorphine to determine any differences in the basic pharmacokinetic parameters. The pharmacodynamic characteristics in each group were studied at different steady-state plasma levels, achieved by iv infusions with continuous measurements of the heart rate. There was an almost twofold decrease in the plasma clearance in the malnourished rats compared with controls. A pronounced change in the pharmacodynamic response was also observed in the malnourished group. In the control group, apomorphine produced bradycardia at low concentrations and tachycardia at high concentrations, while only bradycardia was registered in the malnourished group, with maximum effects at steady-state plasma concentrations of 50 ng/ml and a return to baseline at higher concentrations. The effects in control and malnourished rats were fitted simultaneously to the sum of two Hill equations with a nonlinear regression program, and the fits were compared by means of an F test. The maximum pure tachycardia obtainable differed significantly in the prekwashiorkor group compared to the control group. These results suggest a selective down regulation/desensitization only of the receptors responsible for the tachycardia produced by apomorphine during malnutrition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2362906     DOI: 10.1023/a:1015850802006

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Biological disposition of apomorphine. III. Kinetics of metabolism of apomorphine and role of the liver in its biotransformation.

Authors:  P N KAUL; E BROCHMANN-HANSSEN; E L WAY
Journal:  J Pharm Sci       Date:  1961-03       Impact factor: 3.534

Review 2.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

Review 3.  Drug binding to human alpha-1-acid glycoprotein in health and disease.

Authors:  J M Kremer; J Wilting; L H Janssen
Journal:  Pharmacol Rev       Date:  1988-03       Impact factor: 25.468

4.  Protein binding of salicylic and salicyluric acid in serum from malnourished children: the influence of albumin, competitive binding and non-esterified fatty acids.

Authors:  J M Ashton; P Bolme; G Zerihun
Journal:  J Pharm Pharmacol       Date:  1989-07       Impact factor: 3.765

5.  Cardiac function in severely malnourished Jamaican children.

Authors:  G A Alleyne
Journal:  Clin Sci       Date:  1966-06       Impact factor: 6.124

Review 6.  Undernutrition and the development of brain neurotransmitter systems.

Authors:  R C Wiggins; G Fuller; S J Enna
Journal:  Life Sci       Date:  1984-11-19       Impact factor: 5.037

7.  A neuropharmacological analysis of central nervous system catecholamine systems in development protein malnutrition.

Authors:  J P Leahy; W C Stern; O Resnick; P J Morgane
Journal:  Dev Psychobiol       Date:  1978-07       Impact factor: 3.038

8.  Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor.

Authors:  O Walker; A H Dawodu; L A Salako; G Alván; A O Johnson
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

9.  Interactions of apomorphine with serum and tissue proteins.

Authors:  R V Smith; R B Velagapudi; A M McLean; R E Wilcox
Journal:  J Med Chem       Date:  1985-05       Impact factor: 7.446

10.  Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.

Authors:  U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.